contact us
home

 

DIABETES AND MACROVASCULAR DISEASE

Lugano (Switzerland)
April 19-21, 2001

Please select the abstracts you want to download.
The files are all in Microsoft Word format and for your convenience they are all compressed to save time in downloading them.
If your PC doesn't have Win Zip you can download it for free simply by clicking here.

SCIENTIFIC PROGRAMME


Thursday, April 19, 2001

SESSION 1: SCOPE OF THE PROBLEM AND NEW APPROACHES
Chairs: A. Chait; R. Paoletti

. Topic Speaker
16.30-17.00 Opening Remarks  
17.00-17.45 Use of PPARalpha Agonists for the Treatment of Insulin Resistance and Type II Diabetes Prof. J.-C. Fruchart (France)
17.45-18.00 Discussion .
18.00-18.45 Epidemiology of CVD in Diabetes Prof. J.H. Fuller (UK)
18.45-19.00 Discussion .
19.00 End of the Session .
19.30 Welcome Reception .


Friday, April 20, 2001


morning

SESSION 2: PATHOGENESIS OF VASCULAR DISEASE
Chairs: M.-R. Taskinen; G. Noseda

. Topic Speaker
9.00-9.45 Pathobiology of Atherosclerosis in Diabetes Prof. A. Chait
(USA)
9.45-10.00 Discussion ..
10.00-10.45 Endothelial Dysfunction in Diabetes Prof. H. Yki-Järvinen (Finland)
10.45-11.00 Discussion .
11.00-11.20 Coffee Break .
11.20-12.05 Coagulopathies in Diabetes Prof. I. Juhan-Vague (France)
12.05-12.20

Discussion

 

..
12.20 End of the Session .
12.20-13.30 Lunch .

 

afternoon

SESSION 3: RISK FACTORS OF CVD IN DIABETES
Chairs: R. Holman; H. Yki-Järvinen

. Topic Speaker
13.30-14.15 Relationship of Hypertension and Renal Disease to Atherosclerosis in Diabetes Prof. H.-H. Parving
(Denmark)
14.15-14.30 Discussion ..
14.30-15.15 Lipids and Lipoproteins as CHD Risk Factors in Diabetes Prof. M.-R. Taskinen
(Finland)
15.15-15.30 Discussion .
15.30-15.50 Coffee Break ..
15.50-16.35 CVD Risk Factors Associated with Intra-abdominal Obesity and Insulin Resistance Prof. Y. Matsuzawa
(Japan)

16.35-16.50

16.50-18.20

 

 

 

Discussion

WORKSHOP 1:
Evaluation of Risk Factors in the Clinical Practice
Chairs:
Group 1: J.H. Fuller and M.-R. Taskinen
Group 2: J.D. Brunzell and H.-H. Parving
Group 3: A. Chait and Y. Matsuzawa
Group 4: H. Yki-Järvinen and D.W. Erkelens

 

..
18.20 End of the Session .

 


Saturday, April 21, 2001

morning

SESSION 4: LESSONS FROM CLINICAL TRIALS
Chairs: D.W. Erkelens; U. Keller

. Topic Speaker
9.00-9.45 Effect of Glucose and Glycemic Control Prof. R.R. Holman
(UK)
9.45-10.00 Discussion ..
10.00-10.45 Multifaceted Approach to Atherosclerosis Prevention in Type 1 and 2 Diabetes Prof. J.D. Brunzell
(USA)
10.45-11.00 Discussion .
11.00-11.20 Coffee Break .
11.20-12.05 Clinical Trials: Lipids and Hypertension

Prof. M.-R. Taskinen
(Finland)
Prof. H.-H. Parving
(Denmark)

 

12.05-12.20

Discussion

 

.
12.20 End of the Session .
12.20-13.30 Lunch .

afternoon

SESSION 5: TREATMENT OF VASCULAR DISEASE IN DIABETES
Chairs: A. Chait; J.-C. Fruchart

. Topic Speaker
13.30-14.15 Need for Aggressive Treatment Strategy in Primary and Secondary Prevention Prof.D.W. Erkelens
(The Netherlands)
14.15-14.30 Discussion .
14.30-15.15 How to Treat Acute Coronary Syndromes Prof. L. Rydén
( Sweden)
15.15-15.30 Discussion .
15.30-15.50 Coffee Break .
15.50-16.35 Pleiotropic Effects of Statins in Diabetes and Vascular Diseases Prof. R. Paoletti
(Italy)

16.35-16.50

16.50-18.20

Discussion

WORKSHOP 2:
How to Achieve Optimal Management of Cardiovascular Risk Factors
Chairs:
Group 1: A. Chait and I. Juhan-Vague
Group 2: J. Brunzell and U. Keller
Group 3: R. Holman and L. Rydén
Group 4: H. Yki-Järvinen and G. Noseda

 

..
18.20 End of the Course .

 

 

back
top page